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of the immune system. Common mycoses include athlete’s 
foot and ringworm.
Diagnosis and Treatment of Mycotoxicoses
Different mycotoxins cause different diseases. Although 
they all are called mycotoxicoses, they are very different from 
each other.
Modern agricultural practices make acute mycotoxicoses 
with high death loss (mortality) rare. Chronic myco toxicoses 
are often suspected when clinical signs include poor perfor-
mance, ill thrift, or increased incidence of infectious diseases. 
Establishing cause and effect relationships between consump-
tion of mycotoxin-contaminated feed and vague chronic 
conditions is very difficult.
Diagnosis of mycotoxicoses is usually not very easy. 
Exposure cannot be established by detection of mycotoxins in 
tissues from animals suspected of being poisoned by mycotox-
ins because analytical services for detection of mycotoxins in 
animal tissues are not commonly available. We must rely on 
the detection of mycotoxins in grain or feed to help establish 
the diagnosis.
Investigation of suspected mycotoxicoses should 
begin by obtaining thorough histories. Clinical signs are 
very important because they can be used to select ap-
propriate diagnostic tests to help confirm or refute myco­
toxicoses. Investigation of suspected mycotoxicoses 
should include histopathological examination of tissues from 
affected animals whenever possible. Specific histopathologi-
cal lesions may be evidence of mycotoxicoses. If there are 
no lesions in or evidence of pathology in organs known to be 
effected by mycotoxins, then like lihood of a mycotoxicosis 
is reduced.
Confirmation of suspected mycotoxicoses is assisted by 
either reproducing the clinical disease during a feeding trial 
using the suspected ration, or by detection of a known myco-
toxin in the ration or tissues of animals consum ing the ration. 
Feeding trials are not routinely performed because they are 
difficult to conduct, expensive, and slow to provide results. 
Detection of known myco toxins in feeds is relatively easy 
with modern analytical chemical methods.
One of the most challenging aspects of diagnosing cases 
of suspected mycotoxicoses is collecting a feed sample that 
adequately represents the feed suspected of being contami-
This NebGuide briefly discusses mycotoxins commonly 
encountered in grains and feeds used in Nebraska and the 
mycotoxicoses they cause. Myco toxin sources and clini-
cal signs, lesions, diagnostic aids and treatment for each 
mycotoxicosis are listed.
Mycotoxins are chemicals produced by fungi (molds) 
under certain conditions. They are not essential for fungal 
growth or reproduction, and are toxic to animals or humans. 
Scientists do not yet know how many mycotoxins may ex-
ist, even though more than 250 have been detected. They 
represent many different kinds of chemicals. For many, if 
not most, their toxicological characteristics have not been 
fully determined.
Diseases in animals caused by mycotoxins are called my-
cotoxicoses. There are many different kinds of myco toxicoses 
because there are many different kinds of mycotoxins.
This NebGuide is not intended to allow animal owners 
to diagnose cases of mycotoxicoses without consulting a 
veterinarian. Diagnosing mycotoxicoses is not easy. Other 
diseases besides mycotoxicoses can cause similar clinical 
signs or lesions, and the expertise of a veterinarian is vital 
to accurate diagnoses. Otherwise, valuable resources may be 
worthlessly expended treating wrong diseases.
The medical vocabulary used here may not be familiar 
to some readers. Those words are used to minimize the size 
of this NebGuide. Definitions of unfamiliar words may be 
found in medical dictionaries.
Mycotoxicoses and Mycoses
Diseases called mycotoxicoses and mycoses are 
sometimes confused. They are not the same. Diseases caused 
by mycotoxins are called mycotoxicoses. Diseases caused by 
mold infections are called mycoses.
Mycotoxicoses occur when mycotoxins enter the body, 
usually by consumption of contaminated feed. Ill health is 
caused by actions of mycotoxins on cells in the body. Myco-
toxicoses are not contagious, nor is there significant stimulation 
of the immune system.
Mycoses occur when molds infect tissues of the body. 
They can be contagious. Molds begin to grow in or on the body 
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nated. Mycotoxins are not evenly distributed in feeds, so 
the contaminated part of the feed may be consumed before 
disease is evident. Collection of meaningful feed specimens 
under such conditions is very difficult . More information 
about feed specimen collection and analysis for mycotoxins 
may be found in NebGuide G1515, Sampling and Analyzing 
Feed for Fungal (Mold) Toxins (Mycotoxins).
Interpreting the significance of finding mycotoxins 
present in the ration is difficult. If a mycotoxin is detected 
in feed, the disease it causes should match the clinical syn-
drome observed for the case and its concentrations should be 
sufficient to cause a mycotoxicosis. If not, it is unlikely that 
the presence of the mycotoxin in the feed is significant.
Treatment of animals suffering from mycotoxicoses 
usually is supportive and often not very effective. Antidotes 
for mycotoxins are generally not available. Stopping and 
preventing further exposure by removing contaminated feed 
is important.
It is not uncommon for animals to improve after they 
quit eating feed suspected or known to be contaminated with 
mycotoxins. Such an occurrence supports the suspicion of the 
feed as a causal factor, but does not prove that the animals 
suffered from a mycotoxicosis.
Health effects, clinical signs, lesions and treatment for 
selected mycotoxicoses. (Reference: Osweiler, G.D. (1996) 
Toxicology, William & Wilkins, Media, PA: 416-432.)
Aflatoxicosis
Aflatoxicosis is caused by aflatoxins, produced by Asper-
gillus flavus and Aspergillus parasiticus. Aflatoxins are com-
monly found in corn, milo, cottonseed and peanuts. Aflatoxin 
concentrations in grains produced in Nebraska rarely contain 
enough aflatoxin to cause acute aflatoxicosis.
There are five important aflatoxins, called aflatoxin B1, 
B2, G1, G2, and M1. Aflatoxin M1 is a metabolite of aflatoxin 
B1 found in milk and urine. It is formed after aflatoxin B1 
enters the body. It is not found in feed. Aflatoxin B1 is found 
most frequently and in the highest concentrations in naturally 
contaminated feed.
Aflatoxin is a liver poison (hepatotoxin) in all species 
that consume it, however, ruminants tolerate it better than 
do monogastrics or poultry. It causes liver damage at higher 
doses and liver cancer at lower doses. Aflatoxin exposure can 
depress the immune system. It  may cause abortions in some 
instances, however the circumstances necessary for abortions 
to occur are not well defined.
Clinical signs of aflatoxicoses:
Acute exposure, all species: Depression, anorexia, reduced 
gain or milk production, subnormal body temperature.
Chronic exposure, poultry: Decreased growth rate, reduced 
feed efficiency, steatorrhea (fat in feces), bruising.
Chronic exposure, swine: Anorexia, unthriftiness, slow growth, 
icterus, mild anemia, ascites, increased susceptibility to 
infection.
Chronic exposure, cattle: May slow rumen motility for 24 
to 48 hours.
Lesions of aflatoxicosis:
Acute exposure: Hemorrhage, ascites.
Chronic exposure: Pale, soft, clay-colored liver, mild anemia, 
icterus, ascites.
Histopathological: Hepatocyte degeneration and necrosis; 
centrilobular hemorrhagic hepatic necrosis, fatty changes 
and regeneration of hepatocytes; bile duct epithelial 
proliferation progressing to interlobular fibroplasia and 
extensive proliferation; Karyomegaly, atypical nuclei, 
hepatocytic vacuolization, bile retention.
Diagnostic aids for aflatoxicosis:
Blood workup: Check for anemia, elevated liver enzymes, 
serum bile acids, albumin:globulin ratio; prothrombin 
activity.
Tissue or fluid analysis: Aflatoxin M1 present in milk or urine; 
parent compound may be present in kidney or liver.
Grain or feed analysis: Aflatoxins are most likely to be 
present in corn, peanuts or cotton seed. They are not 
likely to be present in forages or silage at significant 
concentrations. Dietary aflatoxin concentrations at 
which performance or clinical effects become notice-
able depends upon species and effect. Decreased 
per -formance may occur at concentrations as low as 
200 ppb in young, sensitive species. Immunity may 
become impaired at concentrations of about 200 ppb. 
Hepatic lesions may become noticeable at 200 to 400 
ppb. Clinical illness may become obvious at about 400 
ppb. Generally, ruminants are most resistant and swine 
and avian specimens least resistant to adverse effects. 
Violative residues in milk can occur at con centrations at 
or near 50 ppb aflatoxin1. 
Treatment for aflatoxicosis:
Stop exposure. Stop feeding contaminated ration and replace 
with noncontaminated ration.
Supportive treatment. Provide supportive treatment as clinical 
situation dictates.
Ergot Toxicosis
Ergot toxicosis is a disease caused by the ingestion of ergot 
alkaloids contained in the sclerotia of Claviceps spp. They are 
commonly found in cereal grains, especially rye. Tall fescue 
(Festuca arundinaceae) may contain the endophytic fungus 
Neotyphodium coenophialumin (Acre monium coenophialum), 
which can also make ergot alkaloids.
Sclerotia are dark brown, brownish-purple or black 
colored bodies that stick out from the seed heads of infected 
plants. They are visible to the naked eye and look similar to 
rodent droppings when removed from the seed heads. They 
may become quite large, up to an inch in length.
Several different ergot alkaloids may be present in scle-
rotia. They cause two syndromes: a central nervous system 
disorder and a peripheral vascular disorder. They can cause 
agalactia in lactating females.
Ergot alkaloids are potent smooth muscle stimulants. Any 
organ with smooth muscle in it may be affected, especially 
arterioles. Uterine contractions may be stimulated.
Clinical signs of ergot toxicosis:
Peripheral vascular syndrome: Lameness, swelling of feet and 
fetlocks; sharply demarcated necrosis of feet, ears or tail. 
In severe cases, hooves or feet, or tail may slough. Dry 
gangrene. These effects are due to ischemia resulting from 
constriction of arterioles in peripheral vascular beds.
Lactating females: Cessation of milk production; agalactia in 
post-partum females.
Central nervous system syndrome: Hyperexcitability, hyper-
metria, tremors; heat intolerance in cattle.
Lesions of ergot toxicosis:
Described above under clinical signs for peripheral vascu-
lar syndrome. Additionally, small and flaccid mammary glands 
of females in late pregnancy, with no evidence of secretions, 
are indications of probable agalactia.
Histopathological: Endothelial damage, thrombosis, coagula-
tive necrosis.
Diagnostic aids for ergot toxicosis:
Analysis of stomach or rumen content for ergot alkaloids. 
Detection of ergot alkaloids in stomach or rumen content 
is evidence of exposure.
Analysis of feed or grains for ergot alkaloids ingested by af-
fected animals. Sclerotia may be visible if the feed has 
not been ground.
Treatment for ergot toxicosis:
Stop exposure. Remove contaminated grain or feed from ration. 
Lactation may commence 5 to 7 days afterwards.
Control secondary infections in limbs suffering from dry 
gangrene.
Place animals in a warm, clean, stress-free environment.
Fumonisin Toxicosis
Fumonisins are produced by Fusarium moniliforme and 
F. proliferatum, and is found primarily in white and yellow 
corn. There are three kinds, called fumonisins B1, B2, and B3. 
Fumonisin B1 is most prevalent in naturally contaminated corn 
and it is the most toxic.
Horses and pigs are the most sensitive species. Equine 
leukoencephalomalacia (ELE) is a fatal disease of horses 
caused by fumonisins. Porcine pulmonary syndrome is the form 
of the disease in swine. The mechanism of action is believed 
to be the inhibition of enzymes involved in the production of 
sphingosine from sphinganine. Sphingosine is an important 
component of cell membranes, especially for neurons.
Clinical signs of fumonisin toxicosis:
Swine: Dyspnea, cyanosis, and weakness, which develop 4-7 
days after fumonisin-contaminated feed begins. Death may 
occur withing a few hours of onset of the syndrome.
Horses: Depression, blindness, ataxia, aimless wandering, 
facial paralysis, which may rapidly progress to coma and 
death. Death may occur 1 to 7 days after onset of signs.
Ruminants: May develop anorexia and suffer mild weight 
loss if fumonisin concentrations approach 200 ppm. Few 
other significant or persistent signs.
Poultry: Appear to be more resistant than other species. 
Inappetence and skeletal abnormalities may develop 
at concentrations of 200 - 400 ppm.
Lesions of fumonisin toxicosis:
Swine: Acute pulmonary edema characterized by marked 
to massive intralobular pulmonary edema and marked 
hydrothorax. Lungs are distended and turgid. Thoracic 
cavity is filled with straw­colored proteinaceous fluid. 
Microscopically, interstitial and interlobular edema. May 
include multiple areas of focal pancreatic necrosis and 
hepatic lesions characterized by disorganized hepatocytes, 
increased mitotic figures, necrosis of single hepatocytes 
and mild bile retention. Icterus.
Horses: Leukoencephalomalacia – massive softening and liq-
uefaction of cerebral white matter, ranging from discrete 
focal areas to large cavitations and inward collapse of the 
cortical gray matter. Hemorrhage is prominent. Micro-
scopically, liquefaction and proliferation of macrophages 
in response to necrosis.
Diagnostic aids for fumonisin toxicosis:
Blood workup: Evidence of hepatic dysfunction.
Tissue analysis: Sphinganine:sphingosine ratio is increased. 
Analysis of tissues for sphinganine and sphingosine is 
not readily available.
Analysis of corn or corn-containing feed for fumonisins: 
Concentrations in excess of 3 ppm fumonisin may be 
significant for horses. Concentrations above 5 ppm may 
be significant for pigs.
Treatment for fumonisin toxicosis:
Stop exposure. Remove contaminated feed from ration. Be-
cause of the long time between consumption of feed and 
onset of signs, oral detoxification is not recommended.
Supportive treatment – prognosis for horses and pigs suffering 
from advanced stages of the disease is poor.
Vomitoxin (Deoxynivalenol, DON) Toxicosis
Vomitoxin is produced by Fusarium roseum (F. graminear-
um) and F. moniliforme. It is found in corn, wheat, barley, milo 
and occasionally in oats. It is rarely found in hay or forages. 
F. Roseum also produces zearalenone, so DON may also be 
found with zearalenone.
Vomitoxin is a chemical that belongs to a group of myco-
toxins called tricothecenes. There are at least 140 chemicals in 
that class, including T-2 toxin and diacetoxyscripenol (DAS). 
Trichothecenes other than vomitoxin are rarely, if ever, found 
in grain grown in Nebraska.
Vomitoxin is not very toxic, but it is associated with feed 
refusal and decreased feed consumption, which can affect 
animal performance. Concentrations ranging from 5 to 10 
ppm are associated with vomiting in pigs, hence its name. 
Thresholds for decreased feed intake are about 1 ppm in swine 
and 10 to 20 ppm in ruminants.
The mechanism by which vomitoxin acts has not been 
elucidated. Other trichothecenes inhibit protein and nucleic 
acid synthesis.
Cattle are very resistant to the effects of vomitoxin. 
Pigs are more sensitive. There have been reports of health 
effects in dogs from pet foods contaminated with vomitoxin-
containing grains.
Clinical signs of vomitoxin toxicosis:
Swine, dogs, cats – feed refusal, vomiting; cattle – usually 
none, however some reports of feed refusal may by found 
in the scientific literature; poultry – usually none.
Lesions of vomitoxin toxicosis:
No gross or histopathological lesions have been reported in 
animals consuming vomitoxin-contaminated feed.
Diagnostic aids for vomitoxin toxicosis:
Analysis of grains or feeds. Forages are seldom, if ever, con-
taminated with vomitoxin.
Analysis of tissues from affected animals: Not available.
Treatment for vomitoxin toxicosis:
Remove vomitoxin-contaminated grain/feed from ration .
Zearalenone Toxicosis
Zearalenone is produced by Fusarium roseum (F. 
graminearum) and F. moniliforme. It is found in corn, wheat, 
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barley, milo and occasionally in oats. F. Roseum also produces 
vomitoxin (deoxynivalenol, DON), so vomitoxin may also be 
found with zearalenone.
Zearalenone is a chemical that can act similarly to the 
female sex hormone estrogen. Excessive exposure does not 
cause death or abortions, but it can disrupt the estrus cycle 
in females, cause infertility and feminization in males, and 
precocious puberty in sexually immature females. Zearalenone 
content typically found in Nebraska grains is usually not enough 
to adversely affect animals, but unusual environmental condi-
tions during the growing season, or insufficiently dried grain 
put up for storage may increase zearalenone production.
Clinical signs of zearalenone toxicosis:
Clinical signs vary with species, sex and age of the 
animal.
Swine, sexually immature gilts: Behavioral estrus, swollen and 
edematous vulva, enlarged mammary glands, tenesmus 
(spasmodic contraction of anal or bladder sphincter), 
sometimes vaginal or rectal prolapse; clinical signs ap-
pear 2-7 days after exposure begins and subsides 4 to 10 
days after exposure ends.
Swine, mature sows: Exposure early in estrus cycle – sup-
pression of ovulation and signs of estrus that are severe 
and prolonged; exposure mid-cycle – pseudopregnancy, 
anestrus which may persist for 40 to 60 days after ex-
posure stops.
Swine, castrated boars: Enlarged prepuce and nipples.
Swine, immature boars: Reduced libido, retarded testicular 
development.
Swine, mature boars: Not effected unless dietary concentra-
tions reach 200 ppm or higher. Such concentrations are 
rarely encountered in U.S. grains.
Lesions of zearalenone toxicosis:
Lesions are present only in the reproductive system.
Prepubertal gilts: Swollen and edematous vulva; enlarged 
mammary glands; enlarged, hypertrophic and edematous 
uterus. Histopathologically, uterine and vaginal metaplasia 
and follicular atresia.
Mature sows: Retained and functional corpora lutea with 
anestrus. Mammary alveolar development and ductular 
sqamous metaplasia.
Diagnostic aids for zearalenone toxicosis:
Blood workup: Serum analysis for estrogen can help rule out 
an organic hormonal problem.
Tissue or fluid analysis: Not available.
Feed or grain analysis: Since clinical effects are delayed sev-
eral days after ingestion, feed analysis may be of limited 
value. A specimen collected after the problem is noticed 
may not contain detectable amounts of zearalenone. 
Planned retention and dating of feed specimens aids in 
the identification of zearalenone-contaminated feed.
Differential considerations for zearalenone toxicosis:
Other estrogenic chemicals from plants (phyto estrogens) or 
other sources could also produce some of the signs of 
zearalenone toxicosis. An expensive, but possibly valu-
able estrogenic assay of feed is available to help assess 
estrogenic activity of the feed. That assay detects any 
chemical with estrogenic activity that might be present 
in the feed.
Treatment for zearalenone toxicosis:
Stop exposure. Remove contaminated feed and replace with 
un-contaminated feed. Signs may persist for several days 
afterwards.
Decrease zearalenone absorption: Activated charcoal 
may help limit absorption of ingested zearalenone by 
individual animals. Several commercially available 
feed additives are advertized to bind zearalenone and 
help prevent excessive exposure. The efficacy of such 
additives may not have been adequately assessed. Thor-
oughly assess the evidence offered by manu facturers be-
fore using them. Such use may require approval by federal 
regulatory agencies before it can be used legally.
Prevention of Mycotoxicoses
Purchase grain or feed that are free of mycotoxins.
Have feed analyzed for mycotoxins before purchase 
or use. Make mycotoxin analysis a condition of sale. Re-
quire that the seller have the feed analyzed by a suitable 
laboratory before you accept delivery. However, it may be 
difficult to find feed free of mycotoxins sometimes because 
they occur naturally.
Remove grain or feed contaminated with mycotoxins.
 Substitute grain or feed known not to be contaminated.
Use of feed additives to bind mycotoxins.
Mycotoxin binders are commercially available, but 
before purchase, determine if the product can be legally 
used for such purposes. Ask the seller if the product is 
approved under federal law or regulations for use as 
mycotoxin binder. If the seller claims such approval is not 
necessary, or if the seller cannot document approval, consult 
with staff at the Center for Veterinary Medicine (CVM) of 
the U.S. Food and Drug Agency. Its Web site address at the 
time this NebGuide was published is www.fda.gov/cvm/. Or, 
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